Cleared Traditional

K972795 - CARDIO-CARD MANAGEMENT SYSTEM II

K972795 is an FDA 510(k) clearance for CARDIO-CARD MANAGEMENT SYSTEM II, manufactured by Nasiff Assoc., Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 207-day FDA review.

K972795 · Nasiff Assoc., Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1998
Decision
207d
Days
Class 2
Risk

K972795 is an FDA 510(k) clearance for the CARDIO-CARD MANAGEMENT SYSTEM II. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Nasiff Assoc., Inc. (Brewerton, US). The FDA issued a Cleared decision on February 20, 1998 after a review of 207 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Nasiff Assoc., Inc. devices

FDA 510(k) Submission Details - K972795

510(k) Number K972795 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 1997
Decision Date February 20, 1998
Days to Decision 207 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d slower than avg
Panel avg: 125d · This submission: 207d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 687
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K972795.
CH-611B AND CH-611C DIGITAL WRIST SPHYGMOMANOMETERS BLOOD PRESSURE METER
K973613 · Foley & Lardner · Apr 1998
A&D UB-322 WATCH STYLE WRIST DIGITAL BLOOD PRESSURE MONITOR
K980824 · A&D Engineering, Inc. · Mar 1998
CH-601A AND CH-601B DIGITAL WRIST SPHYGMOMANOMETER (CH-601A/CH-601B)
K973061 · Citizen Watch Co., Ltd. · Mar 1998
RECHARGEABLE BATTERY PART NUMBER GL825-200
K974061 · Alexander Mfg. Co. · Jan 1998
TANGO NON-INVASIVE BLOOD PRESSURE MONITOR
K970629 · Suntech Medical Instruments, Inc. · Jan 1998
BCI MODEL 6004 NIBP MONITOR (6004)
K970801 · Bci Intl., Inc. · Nov 1997